The African swine fever epidemic in West Africa, 1996-2002

African swine fever (ASF) is a contagious, highly fatal, haemorrhagic viral disease that only affects members of the Suidae family. Currently, no vaccine or treatment exists, so the disease has potentially devastating consequences for the pig industries, availability of affordable protein livelihoods and trade. This study aimed to consolidate historical information generated by working towards the control and eradication of ASF in previously unaffected countries in West Africa during 1996–2002. This descriptive analysis entailed the evaluation and review of archived records and reports of outbreaks, data from veterinary services, veterinary consultants and peer‐reviewed publications. Specifically, the analysis focused on establishing the sequence of events in the spread of the disease throughout the region, as well as the possible sources and pathways (mostly human‐driven, i.e., movement of pigs and swill feeding). The socio‐economic aspects of the epidemic were also assessed. Finally, the prevention and control measures applied were described and evaluated. Major challenges for control that were identified involved lack of capacity to respond to an outbreak of animal disease and the nature of the pig sector in the affected countries. Most of the pigs were produced in low biosecurity subsistence husbandry systems. Actions taken by producers to limit economic losses due to the epidemic (e.g., illegal selling of pigs and infected pork, hiding of outbreaks) increased the risk of spread and frustrated control efforts. The disease has persisted in an endemic state ever since and has negatively affected pig production and marketing in most of these countries. The analysis of this information will allow a better understanding of the disease dynamics in a region infected for the first time, and learning how the prevention and control interventions that were implemented worked or failed. This will help the development of better tailored, sustainable and locally sound interventions. The authors provide a set of recommendations for ASF prevention and control.http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1865-16822019-02-14hj2018Veterinary Tropical Disease

Review of Participatory Epidemiology Practices in Animal Health (1980-2015) and Future Practice Directions

In this study we combined an inventory of the major applications, geographic regions and diseases covered by participatory epidemiology (PE) activities in the field of animal health since 1980, together with an email discussion forum with PE practitioners from different regions of the world. The inventory included the search of peer-reviewed papers, master and technical reports, conference proceedings, manuals, training materials and projects. The search resulted in a low number of PE activity results until the year 2000, followed by a considerable increase (especially from 2012). Most of the identified activities were implemented in Africa and Asia, and focused on surveillance, disease survey and prioritization, and disease control. Seventy-nine PE practitioners working predominantly in Africa, Asia and Europe (29, 22 and 18 respectively) contributed to the email discussion forum. They proposed various modifications to the existing PE definition and discussed different issues related to the applicatoin of PE, its institutionalization for use in policy development, as well as the priorities for future development. The need to increase the number of PE trained people together with some methodological developments and the application of this methodology in developed countries, were some of the points highlighted during the forum. These factors stress the importance of further developing PE as a useful approach for engaging communities in addressing animal and related public health risks

Review: Vaccines and Vaccination against Lumpy Skin Disease

The geographical distribution of lumpy skin disease (LSD), an economically important cattle disease caused by a capripoxvirus, has reached an unprecedented extent. Vaccination is the only way to prevent the spread of the infection in endemic and newly affected regions. Yet, in the event of an outbreak, selection of the best vaccine is a major challenge for veterinary authorities and farmers. Decision makers need sound scientific information to support their decisions and subsequent actions. The available vaccine products vary in terms of quality, efficacy, safety, side effects, and price. The pros and cons of different types of live attenuated and inactivated vaccines, vaccination strategies, and associated risks are discussed. Seroconversion, which typically follows vaccination, places specific demands on the tools and methods used to evaluate the effectiveness of the LSD vaccination campaigns in the field. We aimed to give a comprehensive update on available vaccines and vaccination against LSD, to better prepare affected and at-risk countries to control LSD and ensure the safe trade of&nbsp;cattle.</p

African swine fever: how can global spread be prevented?

African swine fever (ASF) is a devastating haemorrhagic fever of pigs with mortality rates approaching 100 per cent. It causes major economic losses, threatens food security and limits pig production in affected countries. ASF is caused by a large DNA virus, African swine fever virus (ASFV). There is no vaccine against ASFV and this limits the options for disease control. ASF has been confined mainly to sub-Saharan Africa, where it is maintained in a sylvatic cycle and/or among domestic pigs. Wildlife hosts include wild suids and arthropod vectors. The relatively small numbers of incursions to other continents have proven to be very difficult to eradicate. Thus, ASF remained endemic in the Iberian peninsula until the mid-1990s following its introductions in 1957 and 1960 and the disease has remained endemic in Sardinia since its introduction in 1982. ASF has continued to spread within Africa to previously uninfected countries, including recently the Indian Ocean islands of Madagascar and Mauritius. Given the continued occurrence of ASF in sub-Saharan Africa and increasing global movements of people and products, it is not surprising that further transcontinental transmission has occurred. The introduction of ASF to Georgia in the Caucasus in 2007 and dissemination to neighbouring countries emphasizes the global threat posed by ASF and further increases the risks to other countries